Literature DB >> 18245518

CCR9 homes metastatic melanoma cells to the small bowel.

Ann Richmond1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18245518     DOI： 10.1158/1078-0432.CCR-07-2235

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  12 in total

Review 1.  Chemokines in health and disease.

Authors:  Dayanidhi Raman; Tammy Sobolik-Delmaire; Ann Richmond
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

Review 2.  Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization.

Authors:  Neta Erez; Lisa M Coussens
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

3.  Metastatic malignant melanoma of the small bowel--report of two cases.

Authors:  Shirley Sundersingh; Urmila Majhi; Senthil Kumar A Chandrasekar; Ramakrishnan A Seshadri; Suresh Kumar Dakshinamurthy; Kathiresan Narayanaswamy
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 4.  Chemokines and chemokine receptors: new insights into cancer-related inflammation.

Authors:  Gwendal Lazennec; Ann Richmond
Journal:  Trends Mol Med       Date:  2010-02-15       Impact factor: 11.951

5.  Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype.

Authors:  Heiko Enderling; Lynn Hlatky; Philip Hahnfeldt
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

Review 6.  The good and the bad of chemokines/chemokine receptors in melanoma.

Authors:  Ann Richmond; Jinming Yang; Yingjun Su
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-14       Impact factor: 4.693

7.  92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts.

Authors:  Beatriz Somovilla-Crespo; Maria Teresa Martín Monzón; Maria Vela; Isabel Corraliza-Gorjón; Silvia Santamaria; Jose A Garcia-Sanz; Leonor Kremer
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

Review 8.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

9.  Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

Authors:  Sonia Chamorro; Maria Vela; Ana Franco-Villanueva; Laura Carramolino; Julio Gutiérrez; Lucio Gómez; María Lozano; Beatriz Salvador; Mónica García-Gallo; Carlos Martínez-A; Leonor Kremer
Journal:  MAbs       Date:  2014-05-07       Impact factor: 5.857

Review 10.  The role of chemokine receptor 9/chemokine ligand 25 signaling: From immune cells to cancer cells.

Authors:  Cong Wang; Zhenghuan Liu; Zhihui Xu; Xian Wu; Dongyang Zhang; Ziqi Zhang; Jianqin Wei
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.